Add-ons: Skin boosters, detox combinations, or post-care therapies might add to the total costs
But if a patient has just a history of restrictive eating disorder, that wont necessarily disqualify them from GLP-1 use
Ann Hematol (2019) 98(2):33950
Semaglutide has been used since 2021 under the brand name, Wegovy, to treat patients with a BMI of 30 or more and patients with a BMI of 27 or more with co-existing weight-related medical problems, including high blood pressure, high cholesterol, obstructive sleep apnea, or heart/vascular disease.[4] As I mentioned above, semaglutide is circulated throughout the body and takes roughly one week to be eliminated through the urine and feces.[5] During its circulation, it interacts with several organs that work together to contribute to weight loss
Leary's massive trench has uncovered barely a trace of hill or moat